Research Paper Volume 15, Issue 20 pp 11554—11570
Comprehensive analysis of transcriptome data and experimental identification show that solute carrier 35 member A2 (SLC35A2) is a prognostic marker of colorectal cancer
Figure 8. Expression of SLC35A2 in colorectal cancer tissues and cells. (A) Representative immunohistochemical staining of SLC35A2 in CRC tumor tissues and matched paracancerous tissues. Strong positive expression of SLC35A2 expression in CRC tissues, weak positive of SLC35A2 expression in matched paracancerous tissues. Scale bar = 50 μm. (B) Western blotting was used to detect the protein expression of SLC35A2 in intestinal epithelium (NCM460) and colorectal carcinoma (HCT116, LOVO). (C) qRT-PCR was used to validate SLC35A2 expression in colorectal carcinoma. (**p < 0.01, ***p < 0.001).